With the surge in CGT approvals and advancements, the industry faces significant pressure to scale production while maintaining stringent quality and safety standards. Traditional manufacturing methods, often rigid and labor-intensive, are inadequate to handle the complexities and variability inherent in cell therapies. As a result, there is an urgent need for flexible and automated solutions to streamline operations, reduce costs, and expedite time-to-market. This webinar explores advanced technologies and strategies that are pivotal in navigating the dynamic CGT landscape.